(Q45879294)

17 December 2017

title

Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism (English)

1 reference

17 December 2017

1 reference

1 reference

Steitz J

1

1 reference

17 December 2017

Brück J

series ordinal

2

1 reference

17 December 2017

Knop J

series ordinal

3

1 reference

17 December 2017

Tüting T

series ordinal

4

1 reference

17 December 2017

publication date

1 August 2001

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

16

1 reference

17 December 2017

page(s)

1255-1263

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301521

exact match

0 references

cites work

The new vaccines: building viruses that elicit antitumor immunity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

DNA immunization targeting the skin: molecular control of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Cancer vaccines based on the identification of genes encoding cancer regression antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Tumor immunity and autoimmunity induced by immunization with homologous DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Coupling and uncoupling of tumor immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Quantitative analysis of the immunopotency of genetically transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: implications for the clinical use of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

Cutting edge: restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

7 January 2021

Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

7 January 2021

Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

7 January 2021

Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

7 January 2021

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

7 January 2021

Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

7 January 2021

Effector and enhancing lymphoid cells in plasmacytoma-bearing mice. I. Methodological studies on the Winn assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301521

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301521

1 reference

17 December 2017

Dimensions Publication ID

1032174031

0 references

1 reference

17 December 2017